Lung scintigraphy for pulmonary embolism diagnosis during the COVID-19 pandemic: does the benefit-risk ratio really justify omitting the ventilation study?

Le Roux, Pierre-Yves; Le Gal, Grégoire; Salaun, Pierre-Yves

Le Roux, Pierre-Yves; Le Gal, Grégoire; Salaun, Pierre-Yves.

Le Roux PY; Service de médecine nucléaire, CHRU de Brest, EA3878 (GETBO), Université de Brest, CHRU Morvan, Médecine nucléaire, 2 avenue Foch, 29609, Brest Cedex, France. pierre-yves.leroux@chu-brest.fr.
Le Gal G; Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada.
Salaun PY; Service de médecine nucléaire, CHRU de Brest, EA3878 (GETBO), Université de Brest, CHRU Morvan, Médecine nucléaire, 2 avenue Foch, 29609, Brest Cedex, France.

Eur J Nucl Med Mol Imaging ; 47(11): 2499-2500, 2020 10.

Article in English | MEDLINE | ID: covidwho-662453

Subject(s)

Coronavirus Infections; Pandemics; Pneumonia, Viral; Pulmonary Embolism; Betacoronavirus; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Coronavirus Infections/diagnosis; Humans; Odds Ratio; SARS-CoV-2; Tomography, Emission-Computed, Single-Photon; Ventilation-Perfusion Ratio

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Pulmonary Embolism / Coronavirus Infections / Pandemics Type of study: Diagnostic study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Eur J Nucl Med Mol Imaging Journal subject: Nuclear Medicine Year: 2020 Document Type: Article Affiliation country: S00259-020-04964-y

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google